IL2 and neoplasm: Deficiencies in IL-2 secretion have been described following suboptimal T-cell activation by reduced recruitment of downstream proteins involved in TCR signaling such as LAT31 and Lck.32 Suboptimal T-cell signaling is associated with T-cell anergy33 which may in part explain reduced capacity for persistent tumor control.